Postprandial reactive hypoglycemia

Diabetes and Metabolism

Volumn 26, Issue 5, 2000, Pages 337-351

  Brun, J F ^a   Fedou, C ^a   Mercier, J ^a  

^a CERAMM   (France)

Author keywords

Breakfast test; Exercise; GLP 1; Glucagon; Hypoglycemia; Insulin sensitivity

Indexed keywords

EXERCISE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN SENSITIVITY; POSTPRANDIAL STATE; REVIEW;

BLOOD GLUCOSE; BODY COMPOSITION; DIABETES MELLITUS; DIAGNOSTIC ERRORS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIA; INSULIN RESISTANCE; INSULINOMA; MALE; MODELS, BIOLOGICAL; PANCREATIC NEOPLASMS; POSTPRANDIAL PERIOD; SYNDROME;

EID: 0033666153     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (148)

1. Hypoglycemia or non-hypoglycemia
2. Glycaemic stability in healthy subjects: Fluctuations in blood glucose concentration during the day
3. Hypoglycemia in adults
4. Hyperinsulinism and dysinsulinism
5. A non-editorial on non-hypoglycemia
6. Non-hypoglycemia is an epidemic condition
7. Heurs et malheurs de l'hyperglycemie provoquee par voie orale
8. a hypoglycaemia
9. Comparison of oral glucose tolerance tests and mixed meals in patients with apparent idiopathic post-absorptive hypoglycemia
10. Reactive hypoglycemia
11. Reactive hypoglycemia
12. Functional hyperinsulinism in general practice
13. Relative hypoglycemia as a cause of neuropsychiatric illness
14. A test of the hypothesis that the rate of fall in glucose concentration triggers counterregulatory hormonal responses in man
15. Epinephrine, norepinephrine, glucagon and growth hormone release in association with physiological decrements in the plasma glucose concentration in normal and diabetic man
16. Reactive hypoglycemia: Mechanism and management
17. Counterregulatory hormonal responses to rapid glucose lowering in diabetic man
18. Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans
19. The use of the plasma epinephrine response in the diagnosis of idiopathic postprandial syndrome
20. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics
21. Psychomotor performance and counterregulatory responses during mild hypoglycaemia in healthy volunteers
22. Hypoglycemic thresholds for cognitive dysfunction in humans
23. Mild hypoglycaemia and impairment of brain stem and cortical evoked potentiels in healthy subjects
24. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction
25. Niveaux de glycemie veineuse physiologiquement associes aux signes fonctionnels d'hypoglycemie. Comparaison avec des hypoglycemies reactionnelles. ALFEDIAM Montreal 7-9 Juin 1995
26. Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man
27. Progressive hypoglycemia's impact on driving simulation performance
28. Le syndrome d'hypoglycemie reactionnelle: Mythe ou realite
29. Hypoglycemia: Post-prandial or reactive
30. Hypoglycemia or non-hypoglycemia
31. Partitioning the symptoms of hypoglycemia using multi-sample confirmatory factor analysis
32. The diagnosis of postprandial hypoglycemia
33. Postprandial hypoglycemia
34. Prevalence of post-glucose-load glycosuria and hypoglycemia in a group of healthy young men
35. Spontaneous hypoglycemia in man
36. The breakfast tolerance test: A return to physiology
37. Elevated hypoglycemic index, and late hyperinsulinism in symptomatic postprandial hypoglycemia
38. Blood glucose measurements during symptomatic episodes in patients with suspected postprandial hypoglyceniia
39. Glucose tolerance test vs. meal test in reactive hypoglycemia
40. Glucose tolerance test vs. meal test in reactive hypoglycemia
41. Absence of hypoglycemia after a test meal in patients with idiopathic reactive hypoglycemia
42. Comparison of the metabolic response to a glucose tolerance test and a standardized test meal and the response to serial test meals in normal healthy subjects
43. Mixed meal tolerance test and reactive hypoglycemia
44. Oral glucose tolerance test compared with a mixed meal in the hypoglycemia. A caveat on simulation
45. Evaluation of a standardized hyperglucidic breakfast test in postprandial reactive hypoglycaemia
46. Etude de la glycoregulation a l'aide d'un petit dejeuner standardise chez 21 obeses
47. Hypoglycemic disorders
48. Lack of C-peptide suppression by exogenous hyperinsulinemia in subjects with symptoms suggesting reactive hypoglycemia
49. Late post-prandial hypoglycaemia as the sole presenting feature of secreting pancreatic beta-cell adenoma in a subtotally gastrectomized patient
50. Postprandial (reactive) hypoglycemia and restless leg syndrome: Related neurologic disorders?
51. Suspected postprandial hypoglycemia is associated with beta-adrenergic hypersensitivity and emotional distress
52. Proarrhythmic effects of reactive hypoglycemia
53. Hypoglycemia in IDDM
54. Plasma insulin in reactive hypoglycemia
55. Epinephrine supports the postabsorbtive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man
56. Counterregulation of hypoglycemia, skeletal muscle glycogen metabolism during three hours of physiological hyperinsulinemia in humans
57. Forearm substrate exchange during hyperinsulinaemic hypoglycaemia In normal man
58. Forearm muscle resistance during hypoglycemia: Role of adrenergic mechanisms and hypoglycemia per se
59. Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin dependent diabetes mellitus
60. Inhibition of muscle glycogen synthase activity and non-oxidative glucose disposal during hypoglycemia in normal man
61. Epinephrine-induced insulin resistance in man
62. Epinephrine inhibits insulin-mediated glycogenolysis but enhances glycolysis in human skeletal muscle
63. Glucose transporters and insulin action. Implications for insulin resistance and diabetes mellitus
64. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes
65. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance
66. Differential regulation of the GLUT-1 and GLUT-4 glucose transport systems by glucose and insulin in L6 muscle cells in culture
67. Opposite effects of acute hypoglycemia and acute hyperglycemia on glucose transport and glucose transporters in perfused rat skeletal muscle
68. Inhibitory effects of epinephrine on insulin-stimulated glucose uptake by rat skeletal muscle
69. The spontaneous hypoglycemias. Importance of etiology in determining treatment
70. Highly increased insulin secretion in a patient with postprandial hypoglycemia: Role of glucagon-like peptide-1 (7-36) amide
71. Physiologic hyperinsulinemia enhances counterregulatory hormone response to hypoglycemia in IDDM
72. Strategie d'exploration des hypoglycemies de l'adulte
73. Hypoglycemie reactive
74. Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy
75. Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia
76. Are abnormalities in insulin secretion responsible for reactive hypoglycemia
77. Glycosurie renale et insulinemie
78. Plasma insulin levels in renal diabetes
79. Increased insulin sensitivity in patients with idiopathic reactive hypoglycemia
80. Increased nonoxidative glucose metabolism in idiopathic reactive hypoglycemia
81. Increased insulin sensitivity and basal insulin effectiveness in postprandial reactive hypoglycaemia
82. Potent glycogenic effect of GLP-1 (7-36) amide in rat skeletal muscle
83. Toward physiological understanding of glucose tolerance. Minimal model approach
84. Quantification of the relationship between insulin sensitivity an b-cell function in human subjects
85. Homeostasis model assessment, insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
86. Revised concept for the estimation of insulin sensitivity from a single sample
87. HOMA and related simplified evaluations of insulin sensitivity from fasting insulin and glucose: No need for log transformation but beware of limits of validity!
88. The glucose clamp technique for the study of patients with hypoglycemia: Insulin resistance as a feature of insulinoma
89. Les hypoglycemies tardives du diabete chimique: Anomalies du glucagon pancreatique, effets de la pectine
90. Idiopathic reactive hypoglycemia: A role for glucagon?
91. Pancreatic alpha-cell function in idiopathic reactive hypoglycemia
92. Reactive hypoglycaemia in association with disordered islet function and abnormal hepatic glucose-6-phosphatase activity: Response to diazoxide
93. An endemic condition of biochemical hypoglycemia among male volunteers
94. Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects
95. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity
96. Interrelation de la masse grasse viscerale et du muscle dans le diabete de type II: Implications pratiques
97. Physical activity and weight maintenance
98. Insulin sensitivity measured with the minimal model is higher in moderately overweight women with predominantly lower body fat
99. The relation of body fat distribution, as assessed by sex girth measurements, to diabetes mellitus in women
100. Contributions of regional adipose tissue depots to plasma lipoprotein concentrations in overweight men and women: Possible protective effects of tight fat
101. Intravenous glucose tolerance test - Derived insulin sensitivity changes during the menstrual cycle
102. Changes in insulin sensitivity, secretion and glucose effectiveness during menstrual cycle
103. Stabilization of plasma glucose during fasting
104. Hypoglycemia in man. Pathologic and physiologic variants
105. Insulin resistance and b-cell dysfunction in aging: The importance of dietary carbohydrate
106. Very-low-energy diets alter the counterregulatory response to falling plasma glucose concentrations
107. Ethanol-induced hypoglycaemia. I. The acute-effects of ethanol on hepatic glucose output and peripheral glucose utilisation in fasted dogs
108. Hypoglycemie post-prandiale et prise d'alcool
109. Lunchtime gin and tonic: A cause of reactive hypoglycaemia
110. Alcohol-potentiated reactive hypoglycaemia depends on the nature of the carbohydrate ingested at the same time
111. Effect of acarbose on the hormonal and metabolic response to the simultaneous ingestion of sucrose and ethanol
112. Potentiation of the plasma insulin response to glucose by prior administration of alcohol. An apparent islet-priming effect
113. Differential plasma insulin response to glucose and glucagon stimulation following ethanol priming
114. Glucose and tolbutamide-mediated insulin response after preinfusion with ethanol
115. Ethanol-induced alterations of glucose tolerance, postglucose hypoglycaemia, and insulin secretion in normal, obese, and diabetic subjects
116. Effect of alcohol on glucose tolerance
117. Effects of ethanol ingestion on glucose tolerance and insulin secretion in normal and diabetic subjects
118. Contributions of gluconeogenesis and glycogenolysis during glucose counterregulation in normal humans
119. Ethanol decreases glucose utilisation in healthy man
120. Acute effects of ethanol and acetate on glucose kinetics in normal subjects
121. The acute effect of ethanol on counterregulatory response and recovery from insulin-induced hypoglycaemia
122. Alcghol causes hypoglycaemic unawareness in healthy volunteers and patients with type 1 (insulin-dependent) diabetes
123. Gin and tonic and reactive hypoglycemia: What is important-the gin, the tonic, or both?
124. Alcohol-provoked hypoglycaemia
125. The association of spontaneous hypoglycemia with hypocalcemia and electro-cerebral dysfunction
126. Effect of calcium infusion on plasma glucose in reactive hypoglycemia
127. L'amelioration de la tolerance au glucose et la correction des hypoglycemies reactionnelles induites par la perfusion intraveineuse de calcium ne peuvent s'expliquer par des modifications de la glucagonemie
128. Long-term treatment with acarbose for the treatment of reactive hypoglycemia
129. Acarbose in reactive hypoglycemia, a double blind study
130. Effect of acarbose on glucose and insulin response to sucrose load in reactive hypoglycemia
131. Therapeutic effect of acarbose in reactive hypoglycemia
132. The use of acarbose in the prevention and treatment of hypoglycaemia
133. Effect of Miglitol (Bay m1099), a new alpha-glucosidase inhibitor, on glucose, insulin, C-peptide and GIP responses to an oral sucrose load in patients with post-prandial hypoglycaemic symptoms
134. Acarbose in the dumping syndrome
135. Acarbose and pectin in the dumping syndrome
136. Low-dose acarbose and the dumping syndrome
137. Effect of acarbose on the hormonal and metabolic response to the simultaneous ingestion of sucrose and ethanol
138. Comparative effects of metformin and indanorex in the treatment of reactive hypoglycemia
139. Cholinergic studies in reactive hypoglycemia
140. Effect of diphenylhydantoin on glucose tolerance in patients with hypoglycemia
141. Functional hypoglycemia: A trial of treatment with phenytoin. Effects on blood sugar and blood insulin curves
142. Chromium and other insulin sensitizers may enhance glucagon secretion: Implications for hypoglycemia and weight control
143. Diazoxide in the management of patients with insulinoma
144. Diazoxide treatment of reactive hypoglycaemia
145. Post-hyperglycaemic hypoglycaemia: Effects of somatostatin
146. Treatment of severe reactive hypoglycemia with a somatostatin analogue (SMS 201-995)
147. Somatization and fashionable diagnoses: Illness as a way of life